Timber Pharmaceuticals Inc. Made Headway
Mon, Jun 05, 2023 at 07:54 PM
Timber Pharmaceuticals Inc. (TMBR:NYSEMKT) rocketted at $1.88, representing a gain of 26.2%. On Mon, Jun 05, 2023, TMBR:NYSEMKT touched a New 2-Week High of $1.88. The stock got featured on our News Catalysts scanner on Mon, Jun 05, 2023 at 09:40 AM in the 'BIOTECH' category. From Mon, May 22, 2023, the stock recorded 44.44% Up Days and 60.00% Green Days
The stock spiked on Mon, Jun 05, 2023 at $2.73 with a volume of 14M+.
About Timber Pharmaceuticals Inc. (TMBR:NYSEMKT)
Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases.
Top 10 Gainers:
- Forza X1 Inc. (FRZA:NASDAQ), 133.6%
- Sevcon, Inc. (SEV:NASDAQ), 76.5%
- Chijet Motor Company Inc. (CJET:NASDAQ), 54.05%
- CIRCOR International, Inc. (CIR:NYSE), 51.06%
- Ucommune International Ltd (UK:NASDAQ), 50.29%
- Mangoceuticals Inc. (MGRX:NASDAQ), 29.46%
- Timber Pharmaceuticals Inc. (TMBR:NYSEMKT), 26.17%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 25%
- WeWork Inc. Class A (WE:NYSE), 24.38%
- Scilex Holding Company Com (SCLX:NASDAQ), 22.78%